Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Ophthalmology"
DOI: 10.1177/1120672119858877
Abstract: Purpose: The aim of this study was to evaluate the effect of half-dose verteporfin photodynamic therapy on central retinal sensitivity, status of fixation stability, and choroidal thickness in patients with chronic central serous chorioretinopathy. Methods:… read more here.
Keywords: verteporfin photodynamic; dose verteporfin; half dose; photodynamic therapy ... See more keywords
Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.
Sign Up to like & getrecommendations! Published in 2018 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_201801_14169
Abstract: OBJECTIVE To observe the curative effect and safety of one-third dose Verteporfin photodynamic therapy (PDT) in the treatment of chronic central serous chorioretinopathy (CSC). PATIENTS AND METHODS A total of 60 patients (68 eyes) treated… read more here.
Keywords: one third; treatment; third dose; months treatment ... See more keywords